HAE Haemonetics Corporation
HAE Haemonetics Corporation
Healthcare · Medical Devices
Market read
Scan convergence 1 scan as of 2026-10-16 1 bull converging
POC $59.58 · VWAP $74.81 · +58.1% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Coverage
1 watchlist
HAE Price Structure
Loading timeframes…
Peers
Every watchlist HAE belongs to, members best 30-day change first — HAE highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@monster-discoveries
Reported EPS $1.14 versus analyst consensus of $1.08 (+5.8%).
full note →Against street estimates
How HAE's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
Recent news
Headlines about HAE from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 9 days ago · Oct 8
- Haemonetics (HAE) Jumps As Citi Hikes Price Target To $123 - StocksToTrade
- Haemonetics stock surges 17% on CSL Plasma supply deal update
- Haemonetics Reports Q1 FY2027: Revenue $339.4M, Adjusted EPS $1.14, Raises FY27 Guidance — TradingView News
- Haemonetics Corporation Announces First Quarter Fiscal 2027 Financial Results Available on Investor Relations Website | Haemonetics Corporation
- Haemonetics Corporation Announces Fourth Quarter Fiscal 2026 Financial Results Available on Investor Relations Website | Nasdaq
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
HAE research tape
70 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.